Literature DB >> 17142781

Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii.

Markus M Heimesaat1, Stefan Bereswill, André Fischer, David Fuchs, Daniela Struck, Julia Niebergall, Hannah-Katharina Jahn, Ildikò R Dunay, Annette Moter, Dorothee M Gescher, Ralf R Schumann, Ulf B Göbel, Oliver Liesenfeld.   

Abstract

Oral infection of susceptible mice with Toxoplasma gondii results in Th1-type immunopathology in the ileum. We investigated gut flora changes during ileitis and determined contributions of gut bacteria to intestinal inflammation. Analysis of the intestinal microflora revealed that ileitis was accompanied by increasing bacterial load, decreasing species diversity, and bacterial translocation. Gram-negative bacteria identified as Escherichia coli and Bacteroides/Prevotella spp. accumulated in inflamed ileum at high concentrations. Prophylactic or therapeutic administration of ciprofloxacin and/or metronidazole ameliorated ileal immunopathology and reduced intestinal NO and IFN-gamma levels. Most strikingly, gnotobiotic mice in which cultivable gut bacteria were removed by quintuple antibiotic treatment did not develop ileitis after Toxoplasma gondii infection. A reduction in total numbers of lymphocytes was observed in the lamina propria of specific pathogen-free (SPF), but not gnotobiotic, mice upon development of ileitis. Relative numbers of CD4(+) T cells did not differ in naive vs infected gnotobiotic or SPF mice, but infected SPF mice showed a significant increase in the frequencies of activated CD4(+) T cells compared with gnotobiotic mice. Furthermore, recolonization with total gut flora, E. coli, or Bacteroides/Prevotella spp., but not Lactobacillus johnsonii, induced immunopathology in gnotobiotic mice. Animals recolonized with E. coli and/or total gut flora, but not L. johnsonii, showed elevated ileal NO and/or IFN-gamma levels. In conclusion, Gram-negative bacteria, i.e., E. coli, aggravate pathogen-induced intestinal Th1-type immunopathology. Thus, pathogen-induced acute ileitis may prove useful to study bacteria-host interactions in small intestinal inflammation and to test novel therapies based on modulation of gut flora.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142781     DOI: 10.4049/jimmunol.177.12.8785

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  214 in total

Review 1.  Monocytes mediate mucosal immunity to Toxoplasma gondii.

Authors:  Ildiko R Dunay; L David Sibley
Journal:  Curr Opin Immunol       Date:  2010-05-27       Impact factor: 7.486

2.  Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality.

Authors:  J P Dubey; L R Ferreira; J Martins; Rima McLeod
Journal:  Parasitology       Date:  2011-11-14       Impact factor: 3.234

Review 3.  An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii.

Authors:  Eric Y Denkers; David J Bzik; Barbara A Fox; Barbara A Butcher
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

4.  Structural shifts of fecal microbial communities in rats with acute rejection after liver transplantation.

Authors:  Yirui Xie; Zhuanbo Luo; Zhengfeng Li; Min Deng; Hao Liu; Biao Zhu; Bing Ruan; Lanjuan Li
Journal:  Microb Ecol       Date:  2012-03-21       Impact factor: 4.552

5.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: induction and control of regulatory T cells in the gastrointestinal tract: consequences for local and peripheral immune responses.

Authors:  Y Belkaid; O Liesenfeld; R M Maizels
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

6.  Elevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice.

Authors:  Eunok Im; Franz Martin Riegler; Charalabos Pothoulakis; Sang Hoon Rhee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-21       Impact factor: 4.052

7.  Campylobacter jejuni induces extra-intestinal immune responses via Toll-like-receptor-4 signaling in conventional IL-10 deficient mice with chronic colitis.

Authors:  B Otto; L-M Haag; A Fischer; R Plickert; A A Kühl; U B Göbel; M M Heimesaat; S Bereswill
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

8.  Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18.

Authors:  D Struck; I Frank; S Enders; U Steinhoff; C Schmidt; A Stallmach; O Liesenfeld; M M Heimesaat
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

Review 9.  Microbial control of regulatory and effector T cell responses in the gut.

Authors:  Timothy Hand; Yasmine Belkaid
Journal:  Curr Opin Immunol       Date:  2010-02-18       Impact factor: 7.486

10.  Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.